Indication
Non-HPV Locally Advanced Head and Neck Cancer
1 clinical trial
1 product
2 drugs
Clinical trial
TRYHARD: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb®) for Non-HPV Locally Advanced Head and Neck Cancer With Concurrent ChemoradiationStatus: Completed, Estimated PCD: 2020-12-01
Drug
CisplatinDrug
placeboProduct
Lapatinib